Your browser doesn't support javascript.
loading
Antagonism of major histocompatibility complex class II invariant chain peptide during chronic lipopolysaccharide treatment rescues autoregulatory behavior.
Van Beusecum, Justin P; Zhang, Shali; Beltran, Estevan; Cook, Anthony K; Tobin, Richard P; Newell-Rogers, M Karen; Inscho, Edward W.
Afiliação
  • Van Beusecum JP; Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Zhang S; Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Beltran E; School of Natural Sciences, University of California, Merced, Merced, California.
  • Cook AK; Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Tobin RP; Division of Surgical Oncology, Department of Surgery, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado.
  • Newell-Rogers MK; Department of Medical Physiology, Department of Medicine, Texas A&M Health Science Center, Temple, Texas.
  • Inscho EW; Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Am J Physiol Renal Physiol ; 317(4): F957-F966, 2019 10 01.
Article em En | MEDLINE | ID: mdl-31432707

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Circulação Renal / Antígenos de Histocompatibilidade Classe II / Lipopolissacarídeos / Homeostase Tipo de estudo: Guideline Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Circulação Renal / Antígenos de Histocompatibilidade Classe II / Lipopolissacarídeos / Homeostase Tipo de estudo: Guideline Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article